Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.029
Sell
RSI(14)
36.418
Neutral
STOCH(KDJ)(9,3,3)
10.668
Oversold
ATR(14)
0.037
High Vlolatility
CCI(14)
-118.810
Sell
Williams %R
85.508
Oversold
TRIX(12,20)
-0.989
Sell
StochRSI(14)
43.643
Buy
Search
Medicus Pharma Ltd
MDCXAdd to Watchlist
0.277USD
+0.015+5.56%
Close 07-31 16:00（ET）Quotes delayed by 15 min
11.09MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+5.56%
5 Days
-25.08%
1 Month
-37.89%
6 Months
-76.71%
Year to Date
-81.88%
1 Year
-88.73%
Key Figures
0.278Open
0.285High
4.20MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
10.50%Turnover Ratio
0.263Prev. Close
0.263Low
893.94KTurnover
LossP/E Static
8.36P/B
0.00%Div Yield TTM
-601.99%ROA
5.10052wk High
2.28Volume Ratio
-11.16MNet Profit
40.00MShares
-2.6248EPS TTM
--Beta
-2949.17%ROE
0.25052wk Low
8.38%Amplitude
--Gross Margin
11.09MMarket Cap
-5.25Reward/Risk
7.04%Risk Rate
Medicus Pharma Ltd News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
4
analysts
Buy
Current Rating
4.500
Target Price
+1566.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Medicus Pharma Ltd
MDCX
4
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Indicators
Moving Average
Indicators
Value
Direction
MA5
0.281
Sell
MA10
0.328
Sell
MA20
0.365
Sell
MA50
0.367
Sell
MA100
0.379
Sell
MA200
1.044
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Medicus Pharma Ltd Info
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. SkinJect Inc., a wholly owned subsidiary of the Company, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver a chemotherapeutic agent to eradicate tumors cells. It is conducting a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-003) in the United States and Europe. It has also commenced a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-004) in the UAE. Its subsidiary, Antev Limited, is a late clinical stage biotech company, developing Teverelix, a GnRH antagonist, as a first in market product for cardiovascular high-risk advanced prostate cancer patients and patients with first acute urinary retention relapse episodes due to enlarged prostate.
Ticker SymbolMDCX
CompanyMedicus Pharma Ltd
CEOBokhari (Raza)
Websitehttps://medicuspharma.com/
Shareholders
Related Instruments
-0.53%
+0.23%
-1.00%
-2.54%
+0.33%
-1.44%
-0.61%
-0.79%
-8.78%
+0.48%
+0.70%
-1.00%
-0.69%
+0.49%
-1.08%
+3.32%
0.00%
+1.34%
-0.87%
-2.17%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Medicus Pharma Ltd (MDCX)?
The current price of Medicus Pharma Ltd (MDCX) is 0.28.
What is the symbol of Medicus Pharma Ltd?
The ticker symbol of Medicus Pharma Ltd is MDCX.
What is the 52-week high of Medicus Pharma Ltd?
The 52-week high of Medicus Pharma Ltd is 5.10.
What is the 52-week low of Medicus Pharma Ltd?
The 52-week low of Medicus Pharma Ltd is 0.25.
What is the market capitalization of Medicus Pharma Ltd?
The market capitalization of Medicus Pharma Ltd is 11.09M.
Is Medicus Pharma Ltd (MDCX) currently rated as Buy, Hold, or Sell?
According to analysts, Medicus Pharma Ltd (MDCX) has an overall rating of Buy, with a price target of 4.50.
What is the Earnings Per Share (EPS TTM) of Medicus Pharma Ltd (MDCX)?
The Earnings Per Share (EPS TTM) of Medicus Pharma Ltd (MDCX) is -2.74.